Clinical Trials Logo

Clinical Trial Summary

The study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat tablets in the same doses.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06414837
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Ninghui Yan
Phone +0518-82342973
Email ninghui.yan@hengrui.com
Status Not yet recruiting
Phase Phase 3
Start date June 2024
Completion date June 2026